Form 8-K Fortress Net Lease REIT For: Jun 15
r
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: ( |
Not Applicable |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
N/A |
|
N/A |
|
N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events.
May 31, 2026 NAV Per Share
On June 15, 2026, Fortress Net Lease REIT (the “Company” or “we”) the Company reported net asset value (“NAV”) per share for each outstanding class of common shares of the Company as of May 31, 2026, which is set forth below:
|
|
NAV per Share |
|
|
Class S |
|
$ |
10.4688 |
|
Class I |
|
$ |
10.5423 |
|
Class F-S |
|
$ |
10.5823 |
|
Class F-I |
|
$ |
10.6526 |
|
Class D-S |
|
$ |
10.9739 |
|
Class E |
|
$ |
11.0405 |
|
Net Asset Value
A detailed calculation of the NAV per share is set forth below. We calculate NAV per share in accordance with the valuation guidelines that have been approved by our board of trustees. Our total NAV presented in the following tables includes the NAV of our outstanding classes of common shares, which includes Class S, Class I, Class F-S, Class F-I, Class D-S and Class E common shares, as well as the partnership interests (“OP Units”) of FNLR OP LP (the “Operating Partnership”), if any, held by parties other than the Company.
The following table provides a breakdown of the major components of our NAV as of May 31, 2026 (amounts in thousands):
Components of NAV |
|
Amount |
|
|
Investments in real estate |
|
$ |
3,250,202 |
|
Intangible assets |
|
|
486,177 |
|
Cash and cash equivalents |
|
|
15,395 |
|
Restricted cash |
|
|
114,769 |
|
Other assets |
|
|
95,327 |
|
Revolving credit facility |
|
|
(1,094,664 |
) |
Term loan |
|
|
(777,521 |
) |
Subscriptions received in advance |
|
|
(114,757 |
) |
Distribution payable |
|
|
(11,107 |
) |
Due to affiliate |
|
|
(12,764 |
) |
Other liabilities |
|
|
(42,557 |
) |
Net Asset Value |
|
$ |
1,908,500 |
|
Number of outstanding shares/units |
|
|
178,509 |
|
The following table provides a breakdown of our total NAV and NAV per share/unit by class as of May 31, 2026 (amounts in thousands, except per share/unit data):
|
|
Net Asset Value |
|
|
Number of Outstanding Shares/Units |
|
|
NAV per Share/Unit as of May 31, 2026 |
|
|||
Class S |
|
$ |
130,507 |
|
|
|
12,466 |
|
|
$ |
10.4688 |
|
Class I |
|
|
272,975 |
|
|
|
25,893 |
|
|
$ |
10.5423 |
|
Class F-S |
|
|
274,562 |
|
|
|
25,945 |
|
|
$ |
10.5823 |
|
Class F-I |
|
|
779,367 |
|
|
|
73,163 |
|
|
$ |
10.6526 |
|
Class D-S |
|
|
407,974 |
|
|
|
37,177 |
|
|
$ |
10.9739 |
|
Class E |
|
|
28,541 |
|
|
|
2,585 |
|
|
$ |
11.0405 |
|
OP Units(1) |
|
|
14,574 |
|
|
|
1,280 |
|
|
$ |
11.3880 |
|
Total |
|
$ |
1,908,500 |
|
|
|
178,509 |
|
|
|
|
|
The following table provides a breakdown of the major components of our NAV as of April 30, 2026 (amounts in thousands):
Components of NAV |
|
Amount |
|
|
Investments in real estate |
|
$ |
3,228,996 |
|
Intangible assets |
|
|
491,282 |
|
Cash and cash equivalents |
|
|
14,843 |
|
Restricted cash |
|
|
70,896 |
|
Other assets |
|
|
64,004 |
|
Revolving credit facility |
|
|
(1,123,065 |
) |
Term loan |
|
|
(777,218 |
) |
Subscriptions received in advance |
|
|
(67,896 |
) |
Distribution payable |
|
|
(10,766 |
) |
Due to affiliate |
|
|
(9,909 |
) |
Other liabilities |
|
|
(44,083 |
) |
Net Asset Value |
|
$ |
1,837,084 |
|
Number of outstanding shares/units |
|
|
172,827 |
|
The following table provides a breakdown of our total NAV and NAV per share/unit by class as of April 30, 2026 (amounts in thousands, except per share/unit data):
|
|
Net Asset Value |
|
|
Number of Outstanding Shares/Units |
|
|
NAV per Share/Unit as of April 30, 2026 |
|
|||
Class S |
|
$ |
96,248 |
|
|
|
9,245 |
|
|
$ |
10.4102 |
|
Class I |
|
|
247,264 |
|
|
|
23,588 |
|
|
$ |
10.4826 |
|
Class F-S |
|
|
271,200 |
|
|
|
25,787 |
|
|
$ |
10.5171 |
|
Class F-I |
|
|
766,514 |
|
|
|
72,408 |
|
|
$ |
10.5862 |
|
Class D-S |
|
|
407,588 |
|
|
|
37,436 |
|
|
$ |
10.8876 |
|
Class E |
|
|
28,300 |
|
|
|
2,583 |
|
|
$ |
10.9541 |
|
OP Units(1) |
|
|
19,970 |
|
|
|
1,780 |
|
|
$ |
11.2162 |
|
Total |
|
$ |
1,837,084 |
|
|
|
172,827 |
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Fortress Net Lease REIT |
|
|
|
|
Dated: June 18, 2026 |
|
By: |
/s/ Avraham Dreyfuss |
|
|
|
Name: Avraham Dreyfuss |
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 1300 Sparebox Research Highlights Tiny Homes And Shipping Container Modifications As Emerging Housing Solution
- Torex Semiconductor Has Achieved "Zero" Current Consumption with Multi-Function Load Switch ICs XC8115/XC8116 Series
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share